Design Therapeutics Inc.

NASDAQ: DSGN · Real-Time Price · USD
5.35
0.19 (3.68%)
At close: Aug 15, 2025, 3:59 PM
5.33
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT

Design Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-63.49M -56.2M -49.59M -47.78M -50.53M -58.67M -66.86M -72.36M -74.28M -69.34M -63.31M -57.03M -50.65M -43.28M -35.53M -28.32M -19.32M -13.13M
Depreciation & Amortization
-6.12M -4.15M -4.16M -4.17M 569K 551K 537K 523K 494K 453K 406K 364K 287K 207K 129K 51K 21K 9K
Stock-Based Compensation
14.11M 13.43M 13.07M 12.32M 12.43M 12.85M 13.09M 13.44M 13.09M 11.99M 10.93M 9.4M 7.78M 6.4M 4.69M 3.55M 2.33M 1.09M
Other Working Capital
310K -770K 226K 444K -855K 371K 2.53M 1.23M -30K -411K -3.39M -2.72M 1.03M -1.12M 61K 448K -899K 1.17M
Other Non-Cash Items
2.29M -769K -1.43M -1.82M -5.12M -3.54M -2.94M -2M -2.45M -2.5M -1.33M -430K 44K 99K -84K -100K -188K -223K
Deferred Income Tax
n/a n/a n/a n/a -1.71M -3.11M -3.11M -3.11M -1.4M n/a n/a 26K 26K 26K 26K n/a n/a n/a
Change in Working Capital
2.58M 233K -993K -4.59M -6.67M -1.65M 728K 2.65M 4.32M 2.48M 1.99M 2.21M 2.8M -957K 1.4M 1.82M 477K 2.54M
Operating Cash Flow
-50.64M -47.45M -43.1M -46.04M -51.03M -53.58M -58.56M -60.85M -60.22M -56.91M -51.32M -45.45M -39.72M -37.51M -29.38M -22.99M -16.69M -9.71M
Capital Expenditures
-143K -217K -340K -367K -436K -364K -256K -517K -774K -929K -918K -984K -1.64M -1.58M -1.54M -1.2M -292K -109K
Cash Acquisitions
n/a n/a n/a n/a n/a -12.07K -31.89K -31.12K 31.96K 83.03K 102.85K 102.08K 39K n/a n/a n/a n/a n/a
Purchase of Investments
-256.96M -271.06M -230.18M -239.96M -228.01M -236.75M -224.7M -211.56M -251.01M -346.61M -313M -301.89M -212.2M -81.15M -86.26M -36.36M -44.87M -21.45M
Sales Maturities Of Investments
281.1M 302.49M 274.47M 288M 297.21M 290.53M 277.5M 258M 219.05M 145.84M 92.89M 32.85M 2.16M 6.47M 34.16M 35.97M 51.8M 50.28M
Other Investing Acitivies
n/a n/a n/a n/a n/a 12.07K 31.89K 31.12K -31.96K -5.03K -24.36K -73.29K -14.29K -74.68K -52.11K -389 6.93K 28.82K
Investing Cash Flow
23.99M 31.21M 43.95M 47.68M 68.77M 53.42M 52.54M 45.92M -32.73M -201.67M -220.99M -269.99M -211.64M -76.26M -53.64M -1.59M 6.64M 28.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
361K n/a n/a n/a n/a n/a n/a 339K 339K 339K 339K 194K 194K 194K 194K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a 210K 210K 340K 491K 79K 235K 298K 177K 384K 228K 36K 6K 1K
Financial Cash Flow
648K 516K 513K 751K 763K 534.21K 514.21K 13.34K 491.00 79.00 235.00 298.00 177.00 384.00 379.21K 380.02K 379.99K 379.98K
Net Cash Flow
-26M -15.73M 1.36M 2.39M 18.5M 588K -5.3M -14.57M -92.46M -258.5M -272.07M -315.14M -251.18M -113.38M 296.19M 354.44M 368.94M 397.99M
Free Cash Flow
-50.78M -47.67M -43.45M -46.41M -51.47M -53.94M -58.82M -61.37M -60.99M -57.84M -52.23M -46.44M -41.36M -39.09M -30.91M -24.19M -16.98M -9.82M